Breakthrough Chemistry, Inc. (BKTH)

Breakthrough Chemistry Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Net Income	-0.22	-0.22	-0.19	-0.15
Depreciation & Amortization	0.04	0.04	0.03	-
Asset Writedown & Restructuring Costs	0.04	0.04	0.02	-
Other Operating Activities	-	0.01	0.03	0.08
Change in Accounts Receivable	0.01	-0	-	-
Change in Inventory	0.01	0.01	-0	0.01
Change in Accounts Payable	0.02	0.02	0.03	-0.01
Change in Other Net Operating Assets	0	0	-0	-0
Operating Cash Flow	-0.1	-0.1	-0.09	-0.08
Operating Cash Flow Growth	-	-	-	-
Short-Term Debt Issued	-	-	0.03	0.03
Total Debt Issued	-	-	0.03	0.03
Net Debt Issued (Repaid)	-	-	0.03	0.03
Other Financing Activities	0.1	0.1	0.05	0.07
Financing Cash Flow	0.1	0.1	0.08	0.09
Net Cash Flow	0	0	-0.01	0.02
Levered Free Cash Flow	-	-0.03	-0.16	-
Unlevered Free Cash Flow	-	-0	-0.12	-
Change in Working Capital	0.04	0.03	0.03	-0.01

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error